Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

REPLIGEN CORPORATION

(RGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
All news about REPLIGEN CORPORATION
05/05REPLIGEN  : HC Wainwright Adjusts Repligen's Price Target to $240 From $225, Mai..
MT
05/04REPLIGEN  : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
05/04REPLIGEN  : Posts Rise in Q1 Adjusted Profit, Revenue; Amends 2021 Forecasts
MT
05/04REPLIGEN  : Reported revenue was $142.8 million for the quarter, representing ye..
PU
05/04REPLIGEN CORP  : Results of Operations and Financial Condition, Financial Statem..
AQ
05/04REPLIGEN : Q1 Earnings Snapshot
AQ
05/04REPLIGEN  : Earnings Flash (RGEN) REPLIGEN CORPORATION Posts Q1 Revenue $142.8M,..
MT
05/04REPLIGEN  : Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q1 EPS $0.68, vs...
MT
05/04Repligen Reports First Quarter 2021 Financial Results and Updates Full Year 2..
GL
04/20Repligen to Report First Quarter 2021 Financial Results
GL
04/12REPLIGEN  : HC Wainwright Adjusts Repligen's Price Target to $225 From $168, Mai..
MT
03/18INSIDER TRENDS : Insider Sales Continue 90-Day Trend at Repligen
MT
03/17Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor ..
GL
03/15REPLIGEN  : RGEN) Insider Makes Significant Share Sale
MT
03/12INSIDER TRENDS : 90-Day Insider Selling Trend Prolonged at Repligen
MT
03/03Repligen Corporation to Present at Barclays Global Healthcare Conference
GL
02/25REPLIGEN  : SVB Leerink Adjusts Repligen's Price Target to $250 From $220, Keeps..
MT
02/24REPLIGEN  : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
02/24REPLIGEN  : Reports Growth in Q4 Adjusted Earnings, Revenue; Issues 2021 Targets
MT
02/24REPLIGEN : 4Q Earnings Snapshot
AQ
02/24REPLIGEN CORP  : Results of Operations and Financial Condition, Financial Statem..
AQ
02/24REPLIGEN  : Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q4 EPS $0.52, vs...
MT
02/24REPLIGEN  : Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q4 Revenue $108.6..
MT
02/24Repligen Reports Fourth Quarter and Full Year 2020 Financial Results
GL
02/22Repligen Corporation to Present at 10th Annual SVB Leerink Healthcare Confere..
GL
02/11Repligen to Report Fourth Quarter and Full Year 2020 Financial Results
GL
02/08REPLIGEN  : Navigo Launches COVID-19 Vaccine Purification Resin
MT
02/08Repligen and Navigo Proteins Announce the Launch of an Affinity Resin for the..
GL
01/28REPLIGEN CORP  : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year..
AQ
01/26INSIDER TRENDS : Insider at Repligen Converts Options Amid 90-Day Selling Trend
MT
01/06INSIDER TRENDS : Insider 90-Day Selling Trend Added to at Repligen
MT
01/04Repligen Corporation to Present at 39th Annual J.P. Morgan Healthcare Confere..
GL
2020Repligen Corporation Announces Closing of Public Offering of $312.2 Million, ..
GL
2020REPLIGEN CORP  : Entry into a Material Definitive Agreement, Other Events, Finan..
AQ
2020REPLIGEN  : EC Mergers & Acquisitions advised ARTeSYN on its Sale to Repligen
PR
2020REPLIGEN  : Prices $271.5 Million Public Offering
MT
2020Repligen Corporation Prices Public Offering of Shares of Common Stock
GL
2020Repligen Corporation Announces Proposed Public Offering of Shares of Common S..
GL
2020INSIDER TRENDS : Repligen Insider Continues 90-Day Selling Trend
MT
2020REPLIGEN  : KeyBanc Starts Repligen at Overweight with $241 Price Target
MT
2020REPLIGEN  : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
2020REPLIGEN : 3Q Earnings Snapshot
AQ
2020REPLIGEN CORP  : Results of Operations and Financial Condition, Financial Statem..
AQ
2020REPLIGEN  : Earnings Flash (RGEN) REPLIGEN CORPORATION Posts Q3 EPS $0.40, vs. S..
MT
2020REPLIGEN  : Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q3 Revenue $94.1M..
MT
2020REPLIGEN  : Reports Third Quarter 2020 Financial Results and Updates Full Year 2..
AQ
2020Repligen Reports Third Quarter 2020 Financial Results and Updates Full Year 2..
GL
2020REPLIGEN CORP  : Regulation FD Disclosure, Other Events, Financial Statements an..
AQ
2020REPLIGEN CORPORATION  : Announces Agreement to Acquire Bioprocess Systems Innova..
AQ
2020Repligen Corporation Announces Agreement to Acquire Bioprocess Systems Innova..
GL
2020REPLIGEN  : to Report Third Quarter 2020 Financial Results
AQ
2020Repligen to Report Third Quarter 2020 Financial Results
GL
2020REPLIGEN  : and Navigo Proteins Announce Achievement of Key Milestone in Develop..
AQ
2020REPLIGEN  : and Navigo Proteins Announce Achievement of Key Milestone in Develop..
AQ
2020Repligen and Navigo Proteins Announce Achievement of Key Milestone in Develop..
GL
2020REPLIGEN  : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
2020REPLIGEN : 2Q Earnings Snapshot
AQ
2020REPLIGEN CORP  : Results of Operations and Financial Condition, Financial Statem..
AQ
2020Repligen Reports Second Quarter 2020 Financial Results and Updates Full Year ..
GL
2020Repligen to Report Second Quarter 2020 Financial Results
GL
2020REPLIGEN CORP  : Entry into a Material Definitive Agreement, Financial Statement..
AQ
2020REPLIGEN  : Current report filing
PU
2020REPLIGEN CORP  : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020Repligen Announces Agreement to Acquire Engineered Molding Technology
GL
2020REPLIGEN CORP  : Change in Directors or Principal Officers, Financial Statements..
AQ
2020Repligen Appoints Carrie Eglinton Manner to Board of Directors
GL
2020REPLIGEN CORP  : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
2020REPLIGEN  : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
2020REPLIGEN : 1Q Earnings Snapshot
AQ
2020REPLIGEN CORP  : Results of Operations and Financial Condition, Financial Statem..
AQ
2020Repligen Reports First Quarter 2020 Financial Results and Updates Full Year 2..
GL
2020Repligen to Report First Quarter 2020 Financial Results
GL
2020REPLIGEN CORP  : Change in Directors or Principal Officers, Financial Statements..
AQ
2020Repligen Appoints Rohin Mhatre, Ph.D. to Board of Directors
GL
2020REPLIGEN  : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
1  2  3  4  5Next
Upcoming event on REPLIGEN CORPORATION